ELI LILLY & Co·4

Mar 17, 4:31 PM ET

LUCIANO JUAN R 4

4 · ELI LILLY & Co · Filed Mar 17, 2026

Research Summary

AI-generated summary of this filing

Updated

Eli Lilly Director Juan R. Luciano Receives 16.092-Share Award

What Happened
Juan R. Luciano, a director of Eli Lilly & Co. (LLY), was granted 16.092 shares as an award on 2026-03-16. The grant is reported at $989.12 per share, for a reported aggregate value of approximately $15,917. This was an award (not an open-market purchase or sale).

Key Details

  • Transaction date: 2026-03-16; Form 4 filed: 2026-03-17 (within the typical 2-business-day reporting window).
  • Transaction type/code: A (Award/Grant).
  • Quantity and value: 16.092 shares × $989.12 = ~$15,917.
  • Shares owned after transaction: Not specified in the provided filing excerpt.
  • Footnote: At Luciano’s election, the shares were deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares following the reporting person’s separation from service.

Context
This is a routine director compensation award deferred into stock units, not an outright cash purchase or sale. Deferred director awards are common and do not by themselves indicate the director is buying or selling stock for investment purposes; settlement will occur later per the deferral plan terms.

Insider Transaction Report

Form 4
Period: 2026-03-16
Transactions
  • Award

    Common Stock

    [F1]
    2026-03-16$989.12/sh+16.092$15,91716,817.42 total
Footnotes (1)
  • [F1]At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.
Signature
/s/ Jonathan Groff for Juan R. Luciano, pursuant to authorization on file|2026-03-17

Documents

1 file
  • 4
    wk-form4_1773779494.xmlPrimary

    FORM 4